FIELD: medicine.
SUBSTANCE: method involves administering fixed 3% Prospidine ointment applications applied to the uterine cervix on the immune correction treatment background at the second menstrual cycle half. The uterine cervix is treated with Myramistin solution.
EFFECT: reduced risk of complications.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PRECANCER DISEASES OF THE NECK OF THE WOMB | 1991 |
|
RU2067430C1 |
METHOD FOR PREDICTING PRE-CANCER DISEASES OF UTERINE CERVIX IN WOMEN WITH PAPILLOMA-VIRAL INFECTION | 2006 |
|
RU2310197C1 |
METHOD OF PERSONALIZED TREATMENT OF HPV-ASSOCIATED RECURRENT CHRONIC CERVICITIS BASED ON IMMUNOGENETIC CRITERIA | 2017 |
|
RU2712016C2 |
METHOD OF CHOOSING TACTICS OF MANAGING PATIENTS WITH CERVICAL NEOPLASIA | 2011 |
|
RU2472424C1 |
METHOD FOR TREATING PSEUDOEROSION OF UTERINE CERVIX BY APPLYING LOCOREGIONAL CYTOKINOTHERAPY | 2002 |
|
RU2232027C2 |
METHOD OF COMBINED THERAPY OF CERVICAL DYSPLASIA ASSOCIATED WITH HUMAN PAPILLOMA VIRUSES | 2019 |
|
RU2701525C1 |
METHOD FOR DIAGNOSING SEVERE CERVICAL DYSPLASIA CASES | 2004 |
|
RU2273855C2 |
METHOD OF TREATING CERVICITIS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2018 |
|
RU2688326C1 |
METHOD OF TREATING CERVIX UTERI DYSPLASIA | 0 |
|
SU1837885A3 |
DIAGNOSTIC TECHNIQUE FOR DEGREE OF CERVICAL DYSPLASIA | 2019 |
|
RU2704966C1 |
Authors
Dates
2006-03-20—Published
2004-09-22—Filed